Anti-Nuclear Antibody (ANA) Negative Control Serum

  • Applications
    • IF
  • Code # ANN-1010
  • Size 0.5 mL
  • Price Call for Price
Specifications
  • Application:
    IF
  • Components:

    Vial containing 0.5 mL Anti-Nuclear Antibody (ANA) negative human control serum with protein stabilizer and 0.005% thimerosal. Stable at 2-8 deg C;until labeled expiration date.

  • Description:

    ANA Negative Control Serum is prepared to give less than a 1+ fluorescence when used as supplied (undiluted) in MBL Bion's Immunofluorescent HEp-2 ANA test System.

    INTENDED USE

    MBL Bion ANA Negative Control may be used in the MBL Bion ANA HEp-2 IFA Test System. When used undiluted as provided, the staining should exhibit less than 1+ fluorescence.

  • Product Type:
    Control Serum
  • Research Area:
    Autoimmune
  • Size:
    0.5 mL
References
  1. Laboratory Diagnosis of Viral Infections, Lennette, E.H. (ed), Dekker, New York, 1985.
  2. Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, SixthEdition, Schmidt, N.J. and R.W. Emmons (Eds.), A.P.H.A., Washington, D.C., 1989.
  3. Weller, T.H., A.H. Coons, Fluorescent Antibody Studies with Agents of Varicella and Herpes Zoster Propagated In Vitro, Proc. Soc. Exp. Biol. Med., 86:789-794, 1954.
  4. Riggs, J.L., R.J. Siewald, J.H. Burckhalter, C.M. Downs, T.G. Metcalf, Isothiocyanate Compounds as Fluorescent Labeling Agents for Immune Serum, Am. J. Pathol. 34:1081-1097, 1958.
  5. Goldman, M.: Fluorescent Antibody Methods. New York, Academic Press, 1968.
  6. Kawamura, A. Jr.: Fluorescent Antibody Techniques and Their Application. Baltimore, University Park Press, 1969.
  7. Nairn, R.C.: Fluorescent Protein Tracing, Baltimore, Williams and Wilkins, 3rd Ed., 1969.
  8. Johnson, R.B., and R. Libby, Separation of Immunoglobulin M (IgM) Essentially Free of IgG From Serum in Systems Requiring Assay of IgM-Type Antibodies Without Interference From Rheumatoid Factor, J. Clin. Micro. 12:451-454, 1980.
  9. Gispen, R., J. Nagel, B. Brand-Saathof, S. DeGraff, Immunofluorescence Test for IgM Rubella Antibodies in Whole Serum After Absorption with Specific Anti-gamma Fc, Clin. Exp. Immunol., 22:431-437, 1975.
  10. Joassin, L., M. Reginster, Elimination of Nonspecific Cytomegalovirus Immunoglobulin M Activities in the Enzyme-Linked Immunosorbent Assay by Using Antihuman Immunoglobulin G, J. Clin. Microbiol. 23:576-581, 1986.
  11. Lyerla, H.C., F.T. Forrester, The Immunofluorescence (IF) Test, in: Immunofluorescence Methods in Virology, USDHHS, Georgia, 71-81, 1979.
  12. Keller, R., R. Psitchel, J.N. Goldman et al., An IgG-Fc Receptor Induced in Cytomegalovirus-Infected Human Fibroblasts, J. Immuno., 116:772-777, 1976.
  13. Westmoreland, D., J.F. Watkins, The IgG Receptor Induced by Herpes Simplex Virus: Studies Using Radioiodinated IgG, J. Gen. Virol., 24:167-178, 1974.
  14. Holborow, E.J., D.M. Weir, G.D. Johnson, A Serum Factor in Lupus Erythematosus With Affinity for Tissue Nuclei, Br. Med. J., 11:732-734, 1957.
  15. Berg, P.A., I. Roitt, D. Doniach, H.M. Cooper, Mitochondrial Antibodies in Primary Biliary Cirrhosis, Immunol. 17:281-293, 1969.
  16. Chernesky, M.A., C.G. Ray, T.F. Smith, Laboratory Diagnosis of Viral Infections, Cumitech 15, ASM, Washington, D.C., March 1982.
  17. Schmidt, N.J., Update on Class-specific Viral Antibody Assays, Clinical Immunology Newsletter, 5: 81-85, June, 1984.18.
  18. Gardner, P.S., J. McQuillin, Rapid Virus Diagnosis: Application of Immunofluorescence, In: Detection of Virus Specific IgM by Immunofluorescence, Butterworth, Boston, 259-287, 1980.
  19. Data on file, MBL Bion, Des Plaines, IL.